Understanding and Enhancing Health-related Social Needs (HRSN) Screening among Community Oncology Practices
This study evaluates health related social needs screening in community oncology clinics.
Inclusion Criteria
- * PART 1: * NCORP PRACTICES: ** Must be an affiliate or sub-affiliate of an NCORP Community or Minority Underserved Community site ** Must provide outpatient oncology care ** Must be a NCORP practice (defined as one or more NCORP affiliates/sub-affiliates, that have a common administrative structure and share providers and/or patients) ** Must have identified two or more Practice Staff that are available and willing to participate on the Practice Interest Form ** Must have identified at least 1-3 outpatient oncology clinics willing to participate on the Practice Interest Form * CLINICS: ** 1-3 clinics within the practice should be selected ** Clinics may or may not be located in different physical locations ** We will encourage NCORP practices to select clinics within a practice that differ in current or potential implementation of HRSN screening (e.g., different clinic workflow or staff, different screening triggers, different tools), so that heterogeneity within NCORP practices can be captured ** Clinics must be willing to allow Practice Staff participants to observe the clinical operations in-person * PRACTICE STAFF: ** Must be willing and able to take time to observe in person and document 1-3 selected clinics within your practice (approximately 2-3 hours per clinic) ** Must be staff at the selected and enrolled practice. Suggestions of appropriate staff are CCDR Lead, research nurse, clinical research coordinator or NCORP Administrators. Staff members with primary clinical roles may also be appropriate, if available ** Must be willing and able to participate in two 1.5 hour virtual training sessions ** Must be willing to interview Clinic Key Informants (approximately 30 minutes per interview; in-person or remotely over the internet or by phone) ** If your clinic is chosen for Part 2, must be willing to schedule an interview between Clinic Key Informant and Wake Forest HRSN Study Team or designee ** If your clinic is chosen for Part 3, must be willing to participate in a three hour or two 1.5 hour in-person (if possible) workshop(s). If your clinic schedules an in-person workshop, there will be no hybrid or separate virtual option for those that cannot attend ** Must be willing to be recorded when participating in interviews and the workshop * CLINIC KEY INFORMANT: ** Must be willing to participate in Part 1 Operational Assessment, which involves a semi-structured interview (approximately 30 minutes; in-person or remotely over the internet or by phone) and a brief non-patient demographics Survey (approximately 5 minutes) ** If your clinic is chosen for Part 2, must be willing to participate in an additional 45 minute interview (remotely over the internet or by phone) ** If your clinic is chosen for Part 3, must be willing to participate in a three hour or two 1.5 hour in-person (if possible) workshop(s). If your clinic schedules an in-person workshop, there will be no hybrid or separate virtual option for those that cannot attend ** Must be willing to be recorded when participating in interviews and the workshop * PART 3: * STAFF WORKSHOP PARTICIPANT: ** Must be a clinic stakeholder (e.g., providers, practice managers, etc.) of the selected clinic ** Must be willing and able to participate in a three hour or two 1.5 hour in-person (if possible) recorded workshop. If your clinic schedules an in-person workshop, there will be no hybrid or separate virtual option for those that cannot attend ** Must be willing to be recorded when participating in the workshop * PATIENT WORKSHOP PARTICIPANT: ** Must be a prospective clinic stakeholder (e.g., patient representative) of the selected clinic ** Must be willing and able to participate in a three hour or two 1.5 hour in-person (if possible) recorded workshop. If your clinic schedules an in-person workshop, there will be no hybrid or separate virtual option for those that cannot attend *** If a virtual workshop is scheduled, an email address is required, or a willingness to attend the virtual workshop at the clinic with the staff workshop participants *** If an in-person workshop is scheduled, no email address is required ** Must have received cancer treatment at the selected clinic within the last five years ** Must be willing to be recorded when participating in the workshop
Exclusion Criteria
- * PART 1: *PRACTICE STAFF: ** Unable to understand, read and communicate in English, as the trainings and observations will be documented in English * PART 3: * STAFF WORKSHOP PARTICIPANT: ** Unable to understand, read and communicate in English, as the workshop will be conducted in English * PATIENT WORKSHOP PARTICIPANT: ** Unable to understand, read and communicate in English, as the workshop will be conducted in English
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT06412029.
Locations matching your search criteria
United States
Delaware
Newark
Guam
Tamuning
Illinois
Danville
Effingham
Mattoon
Normal
Peoria
Urbana
Iowa
Ankeny
Des Moines
Maine
Brunswick
Rockport
Maryland
Elkton
Michigan
Flint
Minnesota
Brainerd
Duluth
Minneapolis
Mississippi
Columbus
Grenada
Jackson
New Albany
Oxford
Southhaven
Missouri
Bolivar
Springfield
New York
New York
North Carolina
Pinehurst
North Dakota
Fargo
Pennsylvania
Danville
Puerto Rico
Bayamon
San Juan
South Carolina
Greenville
Tennessee
Collierville
Memphis
Wisconsin
Appleton
Grafton
Kenosha
Milwaukee
PRIMARY OBJECTIVE:
I. Describe current processes for HRSN screening among NCORP clinics and classify clinics in terms of quality and consistency of HRSN screening implementation (high, moderate, low).
OUTLINE: This is an observational study. Participants are assigned to 1 of 3 groups.
GROUP 1 (PART 1): Participants attend training, complete clinic assessments, surveys, and observations and may complete an interview on study.
GROUP 2 (PART 2): Identified clinic staff participants undergo an interview to discuss factors that influence HRSN screening at their clinic and help develop generalized guidance on study.
GROUP 3 (PART 3): Participants attend a co-design workshop and complete surveys on study.
Trial PhaseNo phase specified
Trial Typehealth services research
Lead OrganizationWake Forest NCORP Research Base
Principal InvestigatorEmily Ruth Haines
- Primary IDWF-2303CD
- Secondary IDsNCI-2024-02411
- ClinicalTrials.gov IDNCT06412029